STOCK TITAN

Trulieve Cannabis (TRLV) posts Delaware domestication vote tallies

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Trulieve Cannabis Corp. reported the results of a special meeting of shareholders held on August 5, 2026. Shareholders were asked to vote on a proposal regarding Delaware domestication of the company and on a separate adjournment proposal, both of which had been described in a definitive proxy statement filed on June 25, 2026.

The Delaware domestication proposal received 71,756,586 votes for, 383,078 votes against, and 50,472 abstentions. The adjournment proposal received 71,718,977 votes for, 358,779 votes against, and 112,380 abstentions.

Positive

  • None.

Negative

  • None.

Filing Explained

This 8-K records the August 5 shareholder vote on Delaware domestication, but it does not report that the domestication itself was completed; the filing therefore establishes the voting event, not the resulting corporate-status change.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Delaware domestication votes for 71,756,586 Votes for the Delaware domestication proposal at the August 5, 2026 special meeting
Delaware domestication votes against 383,078 Votes against the Delaware domestication proposal at the August 5, 2026 special meeting
Delaware domestication abstentions 50,472 Abstentions on the Delaware domestication proposal at the August 5, 2026 special meeting
Adjournment proposal votes for 71,718,977 Votes for the adjournment proposal at the August 5, 2026 special meeting
Adjournment proposal votes against 358,779 Votes against the adjournment proposal at the August 5, 2026 special meeting
Adjournment proposal abstentions 112,380 Abstentions on the adjournment proposal at the August 5, 2026 special meeting
Delaware Domestication regulatory
"Proposal No. 1: Approval of Delaware Domestication"
Adjournment Proposal regulatory
"Proposal No. 2: Approval of Adjournment Proposal"
An adjournment proposal is a formal request made at a shareholder or board meeting to pause the meeting and reconvene at a later date or time. It matters to investors because it postpones votes and decisions, giving parties extra time to gather information, solicit support, negotiate alternatives or introduce new options — like hitting pause on a group decision to wait for more facts, which can alter outcomes and market reactions.
special meeting of shareholders regulatory
"held a special meeting of shareholders (the "Special Meeting")"
definitive proxy statement regulatory
"described in detail in the Company's definitive proxy statement filed"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Trulieve Cannabis (TRLV) shareholders vote on at the August 5, 2026 special meeting?

Shareholders voted on a Delaware domestication proposal and a separate adjournment proposal. Both items were described in Trulieve Cannabis’ definitive proxy statement filed with the SEC on June 25, 2026 before the special meeting.

What were the vote results for Trulieve Cannabis (TRLV) Delaware domestication proposal?

The Delaware domestication proposal received 71,756,586 votes for, 383,078 votes against, and 50,472 abstentions. These tallies reflect shareholder voting at Trulieve Cannabis’ August 5, 2026 special meeting of shareholders.

How did Trulieve Cannabis (TRLV) shareholders vote on the adjournment proposal?

The adjournment proposal received 71,718,977 votes for, 358,779 votes against, and 112,380 abstentions. These figures summarize shareholder responses to the adjournment item at the August 5, 2026 special meeting.

Where can investors find more detail on the Trulieve Cannabis (TRLV) proposals?

Further detail on the proposals is provided in the company’s definitive proxy statement filed June 25, 2026. That document explains the Delaware domestication proposal and the adjournment proposal considered at the August 5, 2026 special meeting.
false000175419500017541952026-08-052026-08-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 8-K
___________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 5, 2026
___________________
TRULIEVE CANNABIS CORP.
(Exact Name of Registrant as specified in its charter)
___________________
British Columbia000-5624884-2231905
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
3494 Martin Hurst Road
Tallahassee, FL 32312
(Address of principal executive offices and zip code)

(850) 298-8866
(Registrant’s telephone number, including area code)
Not Applicable
(Registrant’s name or former address, if change since last report)
___________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Subordinate Voting Shares, no par valueTRLVThe New York Stock Exchange



Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. o

Item 5.07    Submission of Matters to a Vote of Security Holders.

On August 5, 2026, Trulieve Cannabis Corp. (the "Company") held a special meeting of shareholders (the "Special Meeting"). The following are the voting results for the proposals considered and voted upon at the Special Meeting, each of which is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on June 25, 2026.

Proposal No. 1: Approval of Delaware Domestication
Votes ForVotes AgainstAbstain
71,756,586383,07850,472

Proposal No. 2: Approval of Adjournment Proposal
Votes ForVotes AgainstAbstain
71,718,977358,779112,380




Item 9.01.    Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No.
Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Trulieve Cannabis Corp.
By:/s/ Eric Powers
Name:Eric Powers
Title:Chief Legal Officer
Date: August 5, 2026

Filing Exhibits & Attachments

3 documents